Aescia Platform
“A composable pathway engine: Collect, Follow, Remind, Educate, Export. One engine, two products.”
“A continuous-care platform for structured patient follow-up and specialty-clinic workflow. Aescia for Hospitals is an investigational Software as a Medical Device in clinical evaluation through the SAFE-Discharge trial at Royal Prince Alfred Hospital. Aescia for Clinics is a workflow platform for specialty clinics.”
“A composable pathway engine: Collect, Follow, Remind, Educate, Export. One engine, two products.”
“Aescia is a continuous-care platform for the weeks between a high-acuity discharge and the next clinical appointment. It is a privately held healthtech company with operations in Sydney, Australia and Montréal, Canada.”
“Aescia was founded by James Kurrle, a hospital doctor with critical care experience who trained and practised across rural and metropolitan New South Wales (Wagga Wagga and Sydney), and Vasken Dermardiros, a machine-learning PhD from Concordia University. James is the Chief Executive Officer and authors the clinical pathway engine.”
“Aescia operates from Sydney, Australia and Montréal, Canada. 9550-0708 Québec inc. (NEQ 1181312316) holds the platform intellectual property and does the research and development. Aescia Pty Ltd (ABN 96 687 840 517) operates in Australia and New Zealand and is the Australian regulatory applicant.”
Download this profile and inspect its supporting evidence.